Effect of immunosuppression on T-helper 2 and B-cell responses to influenza vaccination

Journal of Infectious Diseases

Volumn 212, Issue 1, 2015, Pages 137-146

  Egli, Adrian ^a,d   Humar, Atul ^e   Widmer, Lukas A ^b   Lisboa, Luiz F ^d   Santer, Deanna M ^d   Mueller, Thomas ^c   Stelling, Joerg ^b   Baluch, Aliyah ^f   O'Shea, Daire ^d   Houghton, Michael ^d   Kumar, Deepali ^e  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

B cells; cellular response; computational model; cytokine profile.; cytokines; Immunosuppression; influenza; T cells; vaccine

Indexed keywords

CD86 ANTIGEN; CYCLOSPORIN; HLA DR ANTIGEN; INFLUENZA VACCINE; INTERLEUKIN 4; MYCOPHENOLATE MOFETIL; PREDNISONE; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); LYMPHOCYTE COUNT; MALE; MATHEMATICAL MODEL; ORGAN TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEROCONVERSION; T LYMPHOCYTE ACTIVATION; TH2 CELL; DRUG EFFECTS; IMMUNOLOGY; MIDDLE AGED; THEORETICAL MODEL; YOUNG ADULT;

ADULT; AGED; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; MALE; MIDDLE AGED; MODELS, THEORETICAL; TH2 CELLS; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84936753771     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv015     Document Type: Article

References (38)

1. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-6.
2. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-91.
3. Danziger-Isakov L, Kumar D; AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant 2013; 13(suppl 4): 311-7.
4. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011; 11:2020-30.
5. Cordero E, Manuel O. Influenza vaccination in solid-organ transplant recipients. Cur Op Organ Transplant 2012; 17:601-8.
6. Baluch A, Humar A, Eurich D, et al. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant 2013; 13: 1026-33.
7. Hayney MS, Moran J, Wiegert NA, Burlingham WJ. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons. Vaccine 2008; 26:2596-600.
8. Keshtkar-Jahromi M, Argani H, Rahnavardi M, et al. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephro 2008; 28:654-60.
9. Sanchez-Fructuoso AI, Prats D, Naranjo P, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000; 69:436-9.
10. Salles MJ, Sens YA, Boas LS, Machado CM. Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplan 2010; 24:E17-23.
11. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-7.
12. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95.
13. O'Shea D, Widmer LA, Stelling J, Egli A. Changing face of vaccination in immunocompromised hosts. Cur ID Reports 2014; 16:420.
14. McCullers JA, Huber VC. Correlates of vaccine protection from influenza and its complications. Hum Vaccin Immunother 2012; 8:34-44.
15. Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nature Med 2012; 18:274-80.
16. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009; 9:2346-54.
17. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Mauer JR. Cellmediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant 2004; 23:1175-81.
18. World Health Organization. Immunization, vaccines, and biologicals. http://www.who.int/vaccine-research/diseases/influenza/Guidelines-regulatory-preparedness-pandemic-influenza-vaccines.pdf. Accessed October 2014.
19. Egli A, Silva M Jr, O'Shea D, et al. An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients. PLoS One 2012; 7:e43937.
20. Hindmarsh AC, Brown PN, Grant KE, et al. SUNDIALS: suite of nonlinear and differential/algebraic equation solvers. ACM Trans Math Softw 2005; 31:363-96.
21. Villaverde AF, Egea JA, Banga JR. A cooperative strategy for parameter estimation in large scale systems biology models. BMC Syst Biol 2012; 6:75.
22. Zamora-Sillero E, Hafner M, Ibig A, Stelling J, Wagner A. Efficient characterization of high-dimensional parameter spaces for systems biology. BMC Syst Biol 2011; 5:142.
23. Alam S, Knowlden ZA, Sangster MY, Sant AJ. CD4T cell help is limiting and selective during the primary B cell response to influenza virus infection. J Virol 2014; 88:314-24.
24. Paul WE, Ohara J. B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol 1987; 5:429-59.
25. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
26. Adler-Moore J, Munoz M, Kim H, et al. Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine. Vaccine 2011; 29:4460-8.
27. Baluch A, Humar A, Egli A, et al. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS One 2011; 6:e28627.
28. Cowan M, Chon WJ, Desai A, et al. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation 2014; 97:846-53.
29. Wahl A, Schafer F, BardetW, Buchli R, Air GM, Hildebrand WH. HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci USA 2009; 106:540-5.
30. Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Res 2011; 162:19-30.
31. Clegg CH, Roque R, Van Hoeven N, et al. Adjuvant solution for pandemic influenza vaccine production. Proc Natl Acad Sci USA 2012; 109:17585-90.
32. Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007; 25:3871-8.
33. McElhaney JE, Upshaw CM, Hooton JW, Lechelt KE, Meneilly GS. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16:1742-7.
34. Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev 2009; 229:271-93.
35. Ganschow R, Lyons M, Kemper MJ, Burdelski M. B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient. Ped Transplantation 2001; 5:60-3.
36. Eickenberg S, Mickholz E, Jung E, Nofer JR, Pavenstadt HJ, Jacobi AM. Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus. Arthritis Res Ther 2012; 14:R110.
37. Karnell JL, Karnell FG III, Stephens GL, et al. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. J Immunol 2011; 187:3603-12.
38. Heinschink A, Raab M, Daxecker H, Griesmacher A, Muller MM. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. Clinica Chimica Acta 2000; 300:23-8.